HALO logo
halo search icon
XORTX Therapeutics, Inc.

CA$3.54

Price Change Indicator
0.00 (0.00%)
XORTX Therapeutics, Inc.
XRTX · TSX

XORTX Therapeutics, Inc.

Start Trading XRTX for Free

CA$3.54

0.00 (0.00%)
19/05/2026 12:00:00 AM
All-CompaniesAll-ConsensusHALO All
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

XORTX Therapeutics, Inc. Overview

XRTX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About XRTX

icon

Website

XORTX Therapeutics, Inc.

icon

Telephone

1.403.455.7717

icon

Address

3710-33rd Street NW, Calgary, AB T2L 2M1

Description

XORTX Therapeutics, Inc. is a biopharmaceutical company. The firm engages in development and commercialization of innovative therapies. It focuses on drug therapies for rare orphan disease indications such as polycystic kidney disease, and the treatment of health consequences caused by chronic high serum uric acid or hyperuricemia, including Type 2 Diabetic Nephropathy, cardiovascular disease, and diabetes. The company was founded by Allen Davidoff on May 31, 2011 and is headquartered in Calgary, Canada.

XRTX Price Chart

Key Stats

Market Cap

CA$4.93M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 2.42 - 9.85

Trade Value (12mth)

US$1,096.00

1 week

0%

1 month

-9.23%

YTD

-11.5%

1 year

-51.51%

All time high

449.05

Key Fundamentals

EPS 3 yr Growth

-88.60%

EBITDA Margin

0.00%

Operating Cashflow

-$3m

Free Cash Flow Return

-101.10%

ROIC

-97.00%

Interest Coverage

0.00

Quick Ratio

1.60

Other Data

Shares Outstanding (Fully Diluted)

1m

HALO Sector

Healthcare

Next Company Report Date

01-Apr-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

XRTX Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-5.44-5.76-2.81locklocklock
EPS (Fully Diluted)
 $locklocklocklock-5.44-5.76-2.81locklocklock
Growth
 %locklocklocklock77.9-5.751.3locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of XORTX Therapeutics, Inc. (XRTX:TSX)?
Halo FAQ
The current share price of XORTX Therapeutics, Inc. (XRTX:TSX) is CAD$3.54.
What is the 52-week high share price for XORTX Therapeutics, Inc. (XRTX:TSX)?
Halo FAQ
The 52-week high share price for XORTX Therapeutics, Inc. (XRTX:TSX) is CAD$9.85.
What is the 52-week low share price for XORTX Therapeutics, Inc. (XRTX:TSX)?
Halo FAQ
The 52-week low share price for XORTX Therapeutics, Inc. (XRTX:TSX) is CAD$2.42.
What is the dividend yield for XORTX Therapeutics, Inc. (XRTX:TSX)?
Halo FAQ
XORTX Therapeutics, Inc. (XRTX:TSX) does not pay a dividend.
What was XORTX Therapeutics, Inc. (XRTX:TSX) last dividend payment?
Halo FAQ
XORTX Therapeutics, Inc. (XRTX:TSX) does not pay a dividend.
What is the franking level for XORTX Therapeutics, Inc. (XRTX:TSX)?
Halo FAQ
XORTX Therapeutics, Inc. (XRTX:TSX) has a franking level of 0.00%.
In which sector is XORTX Therapeutics, Inc. (XRTX:TSX) classified?
Halo FAQ
XORTX Therapeutics, Inc. (XRTX:TSX) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial